Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.
Geschäft · 18.3.20261 Min. Lesezeit
Over-the-Counter Monograph Drug Facility Fee Rates for Fiscal Year 2026
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Over-the-Counter Monograph Drug User Fee Amendments (herein referred to as "OMUFA II"), authorizes the Food and Drug Administration (FDA, the Agency, or we) to assess and collect user fees from qualifying manufacturers of over-the-counter (OTC) monograph drugs and submitters of OTC monograph order requests (OMORs) for fiscal years 2026 through 2030. This notice publishes the OTC monograph drug facility (MDF) fee rates for fiscal year (FY) 2026.
Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →